BioCentury
ARTICLE | Financial News

Aclaris raises $20M in private placement

May 28, 2016 1:05 AM UTC

Aclaris Therapeutics Inc. (NASDAQ:ACRS) raised $20 million through the sale of 1.1 million shares at $18.50 in a private placement led by new investor Aisling Capital. Undisclosed new and existing investors also participated. William Blair and Guggenheim Securities were the placement agents. The price is a 6% discount to Aclaris' close of $19.70 on Thursday, before the deal was announced. Aclaris gained $0.30 to $20 on Friday.

Aclaris' share price has slipped since reaching an intraday high of $33.88 on Dec. 17, 2015. In October, the company priced its IPO at $11, raising $55 million (see BioCentury Extra, Oct. 7, 2015). ...